Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John S Yu

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
ACS Nano|June 20, 2020
Near Infrared Fluorescent Nanoplatform for Targeted Intraoperative Resection and Chemotherapeutic Treatment of GlioblastomaDerek Reichel, Bien Sagong, James Teh, et al.
Journal of Drug Delivery|May 24, 2011
Nanoprodrugs of NSAIDs: Preparation and Characterization of Flufenamic Acid NanoprodrugsBong-Seop Lee, Chi Woo Yoon, Arsen Osipov, et al.
Frontiers in Neurology|February 2, 2019
ZEB1 Is a Transcription Factor That Is Prognostic and Predictive in Diffuse GliomasLincoln A Edwards, Sungjin Kim, Mecca Madany, et al.
Journal for Immunotherapy of Cancer|March 26, 2022
Development of a TCR-like antibody and chimeric antigen receptor against NY-ESO-1/HLA-A2 for cancer immunotherapyXin Liu, Yixiang Xu, Wei Xiong, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|March 15, 2020
A phase I trial of surgical resection with Gliadel Wafer placement followed by vaccination with dendritic cells pulsed with tumor lysate for patients with malignant gliomaJeremy D Rudnick, J Manuel Sarmiento, Benjamin Uy, et al.
Scientific Reports|March 2, 2017
ZEB1 regulates glioma stemness through LIF repressionLincoln A Edwards, Aiguo Li, Dror Berel, et al.
Oncogene|May 10, 2023
Glioma immunotherapy enhancement and CD8-specific sialic acid cleavage by isocitrate dehydrogenase (IDH)-1Ryan Cordner, Michelle Jhun, Akanksha Panwar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2021
A Phase I Study of Autologous Dendritic Cell Vaccine Pulsed with Allogeneic Stem-like Cell Line Lysate in Patients with Newly Diagnosed or Recurrent GlioblastomaJethro L Hu, Oluwaseun A Omofoye, Jeremy D Rudnick, et al.
Molecular Cancer Research : MCR|April 17, 2021
Elevated Asparagine Biosynthesis Drives Brain Tumor Stem Cell Metabolic Plasticity and Resistance to Oxidative StressTom M Thomas, Ken Miyaguchi, Lincoln A Edwards, et al.
Cancer Immunology, Immunotherapy : CII|August 1, 2012
Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastomaSurasak Phuphanich, Christopher J Wheeler, Jeremy D Rudnick, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
ACS Nano|June 20, 2020
Near Infrared Fluorescent Nanoplatform for Targeted Intraoperative Resection and Chemotherapeutic Treatment of GlioblastomaDerek Reichel, Bien Sagong, James Teh, et al.
Journal of Drug Delivery|May 24, 2011
Nanoprodrugs of NSAIDs: Preparation and Characterization of Flufenamic Acid NanoprodrugsBong-Seop Lee, Chi Woo Yoon, Arsen Osipov, et al.
Frontiers in Neurology|February 2, 2019
ZEB1 Is a Transcription Factor That Is Prognostic and Predictive in Diffuse GliomasLincoln A Edwards, Sungjin Kim, Mecca Madany, et al.
Journal for Immunotherapy of Cancer|March 26, 2022
Development of a TCR-like antibody and chimeric antigen receptor against NY-ESO-1/HLA-A2 for cancer immunotherapyXin Liu, Yixiang Xu, Wei Xiong, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|March 15, 2020
A phase I trial of surgical resection with Gliadel Wafer placement followed by vaccination with dendritic cells pulsed with tumor lysate for patients with malignant gliomaJeremy D Rudnick, J Manuel Sarmiento, Benjamin Uy, et al.
Scientific Reports|March 2, 2017
ZEB1 regulates glioma stemness through LIF repressionLincoln A Edwards, Aiguo Li, Dror Berel, et al.
Oncogene|May 10, 2023
Glioma immunotherapy enhancement and CD8-specific sialic acid cleavage by isocitrate dehydrogenase (IDH)-1Ryan Cordner, Michelle Jhun, Akanksha Panwar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2021
A Phase I Study of Autologous Dendritic Cell Vaccine Pulsed with Allogeneic Stem-like Cell Line Lysate in Patients with Newly Diagnosed or Recurrent GlioblastomaJethro L Hu, Oluwaseun A Omofoye, Jeremy D Rudnick, et al.
Molecular Cancer Research : MCR|April 17, 2021
Elevated Asparagine Biosynthesis Drives Brain Tumor Stem Cell Metabolic Plasticity and Resistance to Oxidative StressTom M Thomas, Ken Miyaguchi, Lincoln A Edwards, et al.
Cancer Immunology, Immunotherapy : CII|August 1, 2012
Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastomaSurasak Phuphanich, Christopher J Wheeler, Jeremy D Rudnick, et al.
Pageof 10